MCID: TLN003
MIFTS: 52

Telangiectasis malady

Category: Cardiovascular diseases

Aliases & Classifications for Telangiectasis

About this section

Aliases & Descriptions for Telangiectasis:

Name: Telangiectasis 11 38 13 67
 
Telangiectasia 11 26 49 13

Classifications:



External Ids:

Disease Ontology11 DOID:1272
MeSH38 D013684
NCIt44 C28194

Summaries for Telangiectasis

About this section
Wikipedia:70 Telangiectasias /tɛlˌæn.dʒiː.ɛkˈteɪ.zi.ə/, also known as spider veins or angioectasias, are... more...

MalaCards based summary: Telangiectasis, also known as telangiectasia, is related to coats disease and idiopathic juxtafoveal retinal telangiectasia. An important gene associated with Telangiectasis is ACVRL1 (Activin A Receptor Like Type 1), and among its related pathways are Cardiomyocyte Differentiation through BMP Receptors and ALK2 signaling events. Affiliated tissues include skin, eye and liver, and related mouse phenotypes are respiratory system and muscle.

Related Diseases for Telangiectasis

About this section

Diseases related to Telangiectasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 83)
idRelated DiseaseScoreTop Affiliating Genes
1coats disease11.7
2idiopathic juxtafoveal retinal telangiectasia11.0
3reynolds syndrome10.8
4idiopathic macular telangiectasia type 110.8
5idiopathic macular telangiectasia type 310.8
6stoll alembik finck syndrome10.5ACVRL1, ENG
7retinitis10.5
8cochlear disease10.5ACVRL1, BMPR2
9transvestism10.4ACVRL1, BMPR2
10basophilic carcinoma10.3ATM, SMAD4
11midline cleft of lower lip10.3ACVRL1, ENG
12epithelial-myoepithelial carcinoma10.3ATM, SMAD4
13eosinophilic meningitis10.3ENG, TGFB1
14spinal cord astrocytoma10.3ENG, VEGFA
15homocystinuria caused by cystathionine beta-synthase deficiency10.3ACVRL1, BMPR2, ENG
16vhl-related pheochromocytoma10.3ACVRL1, ENG, SMAD4
17astroblastoma10.3ATM, SMAD4
18arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay10.3NDP, VEGFA
19enamel erosion10.1ACVRL1, ENG, VEGFA
20retinitis pigmentosa 3110.1ACVRL1, SMAD4, SOX18
21glomerulosclerosis, focal segmental, 710.0ENG, SMAD4, TGFB1
22ataxia10.0
23lubani-al saleh-teebi syndrome10.0ACVRL1, BMPR2, TGFB1
24macrocephaly mesodermal hamartoma spectrum10.0BMPR2, TGFB1, TGFBR1
25hypohidrosis10.0BMP6, TGFB1
26humeroradial synostosis10.0BMP6, ENG
27strawberry gallbladder9.9BMP6, TGFB1
28dental pulp disease9.9NDP, TGFB1, VEGFA
29pulmonary arteriovenous fistulas9.9
30arteriovenous fistula9.9
31crest syndrome9.9
32muscular dystrophy9.9
33vertebral artery occlusion9.9ACVRL1, BMPR2, ENG, VEGFA
34paroxysmal nocturnal hemoglobinuria9.8SMAD4, TGFB1, VEGFA
35mediastinum leiomyoma9.8AFP, VEGFA
36familial mitral valve prolapse9.8BMP6, ENG, VEGFA
37cerebritis9.8
38eccrine adenocarcinoma9.8AFP, VEGFA
39burns9.7TGFB1, VEGFA
40choroiditis9.7
41aneurysm9.7
42ectopia lentis, familial9.7BMP6, TGFB1, TGFBR1
43mucinous adenocarcinoma9.7AFP, SMAD4
44naegeli-franceschetti-jadassohn syndrome/dermatopathia pigmentosa reticularis9.6BMP6, TGFB1, VEGFA
45keratitis9.6
46ataxia-telangiectasia9.6
47pseudoxanthoma elasticum9.6
48moyamoya disease9.6
49ectodermal dysplasia9.6
50hemangioma9.6

Graphical network of the top 20 diseases related to Telangiectasis:



Diseases related to telangiectasis

Symptoms for Telangiectasis

About this section

Drugs & Therapeutics for Telangiectasis

About this section

Drugs for Telangiectasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 217)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ClonidineapprovedPhase 42264205-90-72803
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
AKOS001595470
Adesipress
BIDD:GT0547
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
C9H9Cl2N3
CAS-4205-91-8
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
CID2803
Catapres
Catapres- TTS
Catapres-TTS
Catapresan
Catapressan
Catarpres
Catarpres-TTS
Catarpres-TTS (TN)
Catarpresan
Chlofazoline
Chlornidinum
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
Clonidine (JAN/USAN/INN)
Clonidine HCl
Clonidine [USAN:BAN:INN]
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
DB07566
DivK1c_000774
 
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hemiton
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Klofelin
Klofenil
L000193
LS-79606
Lopac-C-7897
Lopac0_000268
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
NINDS_000774
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
ST 155BS
ST-155-BS
ST-155BS
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
Spectrum_001341
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
clonidine
nchembio.79-comp11
nchembio705-10
2
Bevacizumabapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 11968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
3
Estradiolapproved, investigational, vet_approvedPhase 4128350-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol [USAN:INN]
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
 
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon
4
AmantadineapprovedPhase 467768-94-52130
Synonyms:
1-Adamantamine
1-Adamantanamine
1-Adamantanamine (8CI)
1-Adamantylamine
1-Aminoadamantane
1-Aminotricyclo(3.3.1.1(sup 3,7))decane
1-adamantanamine
1-adamantylamine
1-aminoadamantane
138576_ALDRICH
665-66-7 (hydrochloride)
768-94-5
AB00514655
AC-11992
AC1L1CZI
AC1Q4UAF
AC1Q5396
ADAMANTANE,1-AMINO
AKOS000113994
AKOS000119324
Adamantamine
Adamantanamine
Adamantylamine
Amant
Amantadina
Amantadina [INN-Spanish]
Amantadine
Amantadine (INN)
Amantadine Base
Amantadine HCL
Amantadine Hydrochloride
Amantadine [INN:BAN]
Amantadinum
Amantadinum [INN-Latin]
Amantidine
Ambap768-94-5
Aminoadamantane
BIA4304
BIDD:GT0757
BPBio1_000368
BRN 2204333
BSPBio_000334
BSPBio_001570
BSPBio_001822
Bio-0821
C06818
C10H17N
CHEBI:2618
CHEMBL660
CID2130
D07441
DB00915
DivK1c_000815
EINECS 212-201-2
Endantadine
Gen-Amantadine
HMS1791O12
HMS1989O12
HSDB 3202
I14-1101
IDI1_000815
InChI=1/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H
KBio1_000815
KBio2_000390
 
KBio2_002958
KBio2_005526
KBio3_001322
KBioGR_000548
KBioSS_000390
L000868
LS-157049
Lopac-A-1260
Lopac0_000004
Mantadine
MolPort-001-661-700
MolPort-001-760-587
MolPort-001-791-102
NCGC00015036-01
NCGC00015036-07
NCGC00162039-01
NCGC00162039-02
NCGC00162039-03
NCGC00162039-04
NCGC00179597-01
NCIOpen2_001059
NINDS_000815
NSC 341865
NSC341865
NSC83653
OR14310
Oprea1_248648
Pk-Merz
Pk-merz
Prestwick0_000407
Prestwick1_000407
Prestwick2_000407
Prestwick3_000407
SPBio_000002
SPBio_002273
STK298781
Spectrum2_000081
Spectrum3_000291
Spectrum4_000134
Spectrum5_000772
Spectrum_000030
Symadine
Symmetrel
TCMDC-125869
TL8005280
Tricyclo(3.3.1.1(3,7))-decan-1-amine
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine
Tricyclo(3.3.1.1(sup 3.7))decan-1-amine
Tricyclo(3.3.1.13,7)decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-ylamine
Tricyclo[3.3.1.1(3,7)]decane-1-amine
Tricyclo[3.3.1.1(sup3,7)]decan-1-amine
Tricyclo[3.3.1.1^3,7]decan-1-amine
UNII-BF4C9Z1J53
Viregyt
Virosol
WLN: L66 B6 A B- C 1B ITJ BZ
Wiregyt
adamantan-1-amine
adamantan-1-ylamine
amantadine
amantadine hydrochloride
tricyclo[3.3.1.1(3,7)]decan-1-ylamine
tricyclo[3.3.1.1(3,7)]decane-1-amine
tricyclo[3.3.1.1~3,7~]decan-1-amine
5
PolidocanolapprovedPhase 4249002-92-0
Synonyms:
Aethoxy-sklerol
Laureth 9
Laureth-9
Macrogol 9 lauryl ether
 
Nonaethylene glycol monododecyl ether
Nonaethylene glycol monolauryl ether
PEG-9 lauryl ether
Polydocanol
Polyethylene glycol 450 lauryl ether
Polyoxyl 9 lauryl ether
6
Chlorhexidineapproved, vet_approvedPhase 447255-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
7
Pimecrolimusapproved, investigationalPhase 462137071-32-06447131, 17753757
Synonyms:
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-((E)-2-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)-1-methylvinyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,26,26a-hexadecahydro-5,19-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,17,20,21(4H,23H)-tetrone
137071-32-0
33-Epi-chloro-33-desoxyascomycin
33-epi-Chloro-33-desoxyascomycin
ASM 981
ASM-981
ASM-998
CHEMBL1200686
CID6447131
CID6509979
CID6916008
D05480
DB00337
 
Elidel
Elidel (TN)
I06-1252
LS-181798
MolPort-003-666-749
NCGC00167506-01
Pimecrolimus
Pimecrolimus (JAN/USAN/INN)
Pimecrolimus [USAN:INN:BAN]
Pimecrolimusum
S5004_Selleck
SDZ ASM 981
SDZ-ASM 981
SDZ-ASM-981
UNII-7KYV510875
8
Aminolevulinic acidapprovedPhase 4, Phase 3, Phase 2157106-60-5137
Synonyms:
106-60-5
35BEC718-C970-426A-9859-BF58284C60B4
5-ALA
5-Amino-4-oxo-Pentanoate
5-Amino-4-oxo-Pentanoic acid
5-Amino-4-oxopentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Amino-Levulinate
5-Amino-Levulinic acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Aminolevulinic acid
5-amino-levulinate
5451-09-2
AC-054
AC1L18K9
AKOS003587520
ALA
ALA-PDT
Aladerm
Amino-levulinic acid
Aminolevulinate
Aminolevulinic
Aminolevulinic acid
BIDD:GT0260
BSPBio_003407
C00430
CCRIS 8958
CHEBI:17549
CHEMBL601
CID137
CPD000857229
 
D07567
DALA
DB00855
DivK1c_006954
EINECS 203-414-1
I14-10101
KBio1_001898
KBio2_002062
KBio2_004630
KBio2_007198
KBio3_002627
KBioGR_001176
KBioSS_002062
Kerastick
LMFA01100055
LS-101793
Levulinic acid, 5-amino- (8CI)
MLS001333097
MLS001333098
MolPort-001-788-423
NCGC00178086-01
Pentanoic acid, 5-amino-4-oxo- (9CI)
SAM002589919
SMR000857229
SPBio_001843
ST50819610
SpecPlus_000858
Spectrum2_001662
Spectrum3_001654
Spectrum4_000618
Spectrum5_001505
Spectrum_001582
UNII-88755TAZ87
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
delta-aminolevulinic acid
9
Tacrolimusapproved, investigationalPhase 41074104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
10
Azelaic acidapprovedPhase 4, Phase 3, Phase 231123-99-92266
Synonyms:
0C50D8EC-0DB0-4F24-8EFC-2919E1F0D9BF
1,7-Dicarboxyheptane
1,7-Heptanedicarboxylate
1,7-Heptanedicarboxylic acid
1,9-Nonanedioate
1,9-Nonanedioic acid
123-99-9
17265-13-3 (di-hydrochloride salt)
17356-30-8 (mono-hydrochloride salt)
19619-43-3 (unspecified potassium salt)
1tuf
246379_ALDRICH
26776-28-3
27825-99-6 (unspecified hydrochloride salt)
32733-99-6
38900-29-7 (di-lithium salt)
4-02-00-02055 (Beilstein Handbook Reference)
458317_ALDRICH
52457-54-2 (di-potassium salt)
A-9800
A0561
A96150_ALDRICH
AC1L1DAO
AC1Q75FC
AGN-191861
AI3-06299
AKOS000120052
AZ1
AZA
AZELAIC ACID, 95%
Acide azelaique [French]
Acide azélaïque
Acido azelaico
Acido azelaico [Spanish]
Acidum acelaicum
Acidum azelaicum
Acidum azelaicum [Latin]
Anchoate
Anchoic acid
Azalaic Acid
Azalaic acid
Azelaic
Azelaic acid
Azelaic acid (USAN/INN)
Azelaic acid [USAN:INN]
Azelaic acid polyanhydride
Azelaic acid, technical grade
Azelaic polyanhydride
Azelaicacidtech
Azelainic acid
Azelainsaeure
Azelainsäure
Azelate
Azelex
Azelex (TN)
Azleaic Acid
BIDD:GT0315
BRN 1101094
BSPBio_001756
C08261
C9H16O4
CHEBI:48131
CHEMBL1238
CID2266
D03034
DB00548
Dicarboxylic acid C9
DivK1c_000532
EINECS 204-669-1
EU-0100051
Emerox 1110
Emerox 1144
Emery'S L-110
 
Emery's L-110
Finacea
Finacea (TN)
Finevin
HMS1921O11
HMS2092E22
HMS501K14
HSDB 7659
Heptanedicarboxylic acid
I04-0585
IDI1_000532
InChI=1/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13
KBio1_000532
KBio2_000437
KBio2_003005
KBio2_005573
KBio3_001256
KBioGR_000662
KBioSS_000437
LMFA01170054
LS-22779
Lepargylate
Lepargylic acid
Lopac-246379
Lopac0_000051
MLS000069659
MLS001148615
MolPort-001-779-873
N-Nonanedioate
N-Nonanedioic acid
NCGC00014993-01
NCGC00014993-02
NCGC00014993-09
NCGC00093565-01
NCGC00093565-02
NCGC00093565-03
NCGC00093565-04
NCGC00093565-05
NCGC00093565-06
NCGC00093565-07
NINDS_000532
NONANEDIOIC ACID
NSC 19493
NSC19493
Nonandisaeure
Nonandisäure
Nonanedioate
Nonanedioic acid
Nonanedioic acid azelaic acid
Nonanedioic acid homopolymer
Nonanedioic acid, homopolymer
Poly(azelaic anhydride)
Polyazelaic anhydride
SBB060279
SDCCGMLS-0066619.P001
SH-441
SMR000059164
SPBio_001089
SPECTRUM1500648
STL059432
Skinorem
Skinoren
Spectrum2_000995
Spectrum3_000278
Spectrum4_000401
Spectrum5_001304
Spectrum_000057
UNII-F2VW3D43YT
ZK 62498
ZK-62498
acide azelaique
acidum azelaicum
azelaic acid
n-Nonanedioic acid
Ácido azelaico
11
DopamineapprovedPhase 4375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
12
MentholapprovedPhase 423532216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
13
MetforminapprovedPhase 41746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
14
Pioglitazoneapproved, investigationalPhase 4435111025-46-84829
Synonyms:
(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione
(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione
105355-27-9
111025-46-8
198077-89-3
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione
5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione
AB1004597
AC-1021
AC1L1J1Q
AD 4833
AD-4833
Actos
Actos (TN)
Actost
BRD-A48430263-003-02-4
BSPBio_002723
C07675
C19H20N2O3S
CHEBI:8228
CHEMBL595
CID4829
D08378
DB01132
Duetact
Glustin
HMS2089H14
HS-0047
 
HSDB 7322
I06-0089
KBio2_002103
KBio2_004671
KBio2_007239
KBio3_001943
KBioGR_001619
KBioSS_002103
LS-151327
MolPort-002-508-211
NCGC00163128-01
NCGC00163128-02
Pioglitazona
Pioglitazona [INN-Spanish]
Pioglitazone
Pioglitazone HCl
Pioglitazone Hydrochloride
Pioglitazone [BAN:INN]
Pioglitazone [Ban:Inn]
Pioglitazone [INN:BAN]
Pioglitazonum
Pioglitazonum [INN-Latin]
SPBio_001897
Spectrum2_001679
Spectrum3_001002
Spectrum4_001130
Spectrum5_001480
Spectrum5_002067
Spectrum_001623
U 72107
U 72107A
U-72107
U72,107A
UNII-X4OV71U42S
Zactos
nchembio790-comp10
pioglitazone (INN)
pioglitazone HCl
15Adrenergic AgonistsPhase 4, Phase 1, Phase 22877
16Angiogenesis Modulating AgentsPhase 4, Phase 3, Phase 2, Phase 14072
17Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 14095
18Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 121402
19Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 15140
20Angiogenesis InhibitorsPhase 4, Phase 3, Phase 2, Phase 14143
21Adrenergic alpha-2 Receptor AgonistsPhase 4, Phase 1, Phase 2911
22Adrenergic alpha-AgonistsPhase 4, Phase 1, Phase 21625
23Immunosuppressive AgentsPhase 4, Phase 2, Phase 112770
24Estradiol 17 beta-cypionatePhase 41283
25Contraceptive AgentsPhase 41901
26AnalgesicsPhase 4, Phase 211287
27Autonomic AgentsPhase 4, Phase 3, Phase 1, Phase 29774
28HormonesPhase 4, Phase 3, Phase 2, Phase 113979
29Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112767
30Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112778
31EstrogensPhase 4, Phase 22470
32Estradiol 3-benzoatePhase 41283
33Estradiol valeratePhase 41283979-32-8
34insulinPhase 44524
35Insulin, Globin ZincPhase 44523
36SympatholyticsPhase 4, Phase 3555
37Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17793
38Polyestradiol phosphatePhase 41283
39Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 122776
40Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 117734
41MitogensPhase 4, Phase 11526
42Photosensitizing AgentsPhase 4, Phase 3, Phase 2476
43Calcineurin InhibitorsPhase 41597
44EmollientsPhase 4, Phase 1144
45Antirheumatic AgentsPhase 4, Phase 210627
46Dermatologic AgentsPhase 4, Phase 3, Phase 2, Phase 15674
47Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 24295
48Chlorhexidine gluconatePhase 4472
49Antiparkinson AgentsPhase 41527
50Anti-Infective Agents, LocalPhase 41785

Interventional clinical trials:

(show top 50)    (show all 154)
idNameStatusNCT IDPhase
1Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)Unknown statusNCT01052623Phase 4
2Polidocanol Versus Glucose Treatment of Telangiectasia TrialCompletedNCT02657252Phase 4
3Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation TelangiectasiasCompletedNCT00725244Phase 4
4Investigation of Coagulation Parameters in Hereditary Haemorrhagic TelangiectasiaCompletedNCT00230659Phase 4
5Amantadine for Improving Neurologic Symptoms in Ataxia-TelangiectasiaCompletedNCT00950196Phase 4
6Treatment of Lower Extremity Spider Veins With Excel VCompletedNCT01362192Phase 4
7Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of PsoriasisCompletedNCT01111123Phase 4
8A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once DailyCompletedNCT00417937Phase 4
9Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic DermatitisCompletedNCT01202149Phase 4
10Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsCompletedNCT00121316Phase 4
11Response of Individuals With Ataxia-Telangiectasia to Metformin and PioglitazoneRecruitingNCT02733679Phase 4
12Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial TelangiectasiasRecruitingNCT02761174Phase 4
13Photodynamic Therapy for Papulopustular RosaceaRecruitingNCT02075671Phase 4
14Intranasal Bevacizumab for HHT-Related EpistaxisRecruitingNCT02389959Phase 4
15Effect of Avastin in Juxtafoveal TelangiectasiasUnknown statusNCT00406380Phase 3
16Long Term Results of the Canadian Breast IMRT StudyUnknown statusNCT01803139Phase 3
17Intravitreal Bevacizumab for Idiopathic Macular TelangiectasiaCompletedNCT00451763Phase 3
18Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)CompletedNCT00656409Phase 3
19Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01031992Phase 3
20Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic TelangiectasiaCompletedNCT00004654Phase 3
21ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler SyndromeCompletedNCT00355108Phase 3
22Trial of Methyl Aminolevulinate Plus Aktilite in Facial PhotodamageCompletedNCT00629317Phase 3
23Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque PsoriasisCompletedNCT00658788Phase 3
24Isotretinoin in Papular-Pustular RosaceaCompletedNCT00882531Phase 3
25Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular RosaceaCompletedNCT01555463Phase 3
26Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast CancerRecruitingNCT01403779Phase 3
27Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye DiseaseRecruitingNCT02980224Phase 3
28Nadolol Versus Propranolol in Children With Infantile HemangiomasRecruitingNCT02505971Phase 3
29EDS in Ataxia Telangiectasia PatientsNot yet recruitingNCT02770807Phase 3
30Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHTNot yet recruitingNCT02963129Phase 3
31Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)TerminatedNCT02106520Phase 2, Phase 3
32Atralin Gel for the Treatment of RosaceaTerminatedNCT01125930Phase 3
33Exparel as a Nerve Block for Severe Hand PainTerminatedNCT02374320Phase 2, Phase 3
34Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)Unknown statusNCT01402531Phase 2
35Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)Unknown statusNCT01397695Phase 2
36Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective DoseUnknown statusNCT02157987Phase 1, Phase 2
37Endpoint Management Software for Photothermal Stimulation of Macular DiseasesUnknown statusNCT01975103Phase 2
38An Evaluation of PDI-320 in Comparison to Its Monads in Adults With RosaceaUnknown statusNCT01828177Phase 2
39High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal TelangiectasiaCompletedNCT01205035Phase 2
40Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)CompletedNCT00504400Phase 2
41Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).CompletedNCT00211328Phase 2
42Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II StudyCompletedNCT00843440Phase 2
43Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical TrialCompletedNCT00375622Phase 2
44Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01314274Phase 2
45Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile EctasiaCompletedNCT00004327Phase 2
46Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)CompletedNCT00211315Phase 2
47North American Study of Epistaxis in HHTCompletedNCT01408030Phase 2
48Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.CompletedNCT02104271Phase 2
49Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyCompletedNCT00470977Phase 1, Phase 2
50Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2

Search NIH Clinical Center for Telangiectasis


Cochrane evidence based reviews: telangiectasis

Genetic Tests for Telangiectasis

About this section

Genetic tests related to Telangiectasis:

id Genetic test Affiliating Genes
1 Telangiectasia26

Anatomical Context for Telangiectasis

About this section

MalaCards organs/tissues related to Telangiectasis:

35
Skin, Eye, Liver, Bone, Endothelial, Testes, Colon

Animal Models for Telangiectasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Telangiectasis:

40 (show all 20)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.7ACVRL1, BMPR2, ENG, TGFB1, TGFBR1, VEGFA
2MP:00053698.3ACVRL1, BMPR2, ENG, SMAD4, TGFB1, TGFBR1
3MP:00028738.3ACVRL1, BMPR2, ENG, SMAD4, SOX18, TGFBR1
4MP:00053808.1ACVRL1, ATM, BMPR2, ENG, SMAD4, TGFB1
5MP:00107718.1ATM, ENG, SMAD4, SOX18, TGFB1, TGFBR1
6MP:00020068.1AFP, ATM, SMAD4, TGFB1, TGFBR1, VEGFA
7MP:00053978.0ACVRL1, ATM, BMPR2, ENG, SMAD4, TGFB1
8MP:00053818.0ACVRL1, ENG, SMAD4, SOX18, TGFB1, TGFBR1
9MP:00053877.6ATM, BMPR2, GDF2, SMAD4, SOX18, TGFB1
10MP:00036317.6ACVRL1, ATM, BMPR2, ENG, NDP, SMAD4
11MP:00053907.5BMP6, BMPR2, GDF2, NDP, SMAD4, TGFB1
12MP:00053897.5AFP, ATM, BMP6, NDP, SMAD4, TGFB1
13MP:00053867.1ACVRL1, AFP, ATM, BMPR2, ENG, NDP
14MP:00053856.9ACVRL1, BMPR2, ENG, GDF2, NDP, SMAD4
15MP:00053786.8ACVRL1, ATM, BMP6, BMPR2, ENG, SMAD4
16MP:00107686.6ACVRL1, AFP, ATM, BMPR2, ENG, SMAD4
17MP:00053766.6ACVRL1, AFP, ATM, BMPR2, ENG, SMAD4

Publications for Telangiectasis

About this section

Articles related to Telangiectasis:

(show top 50)    (show all 193)
idTitleAuthorsYear
1
Fundus autofluorescence patterns in type 2A idiopathic juxtafoveolar retinal telangiectasis. (21786266)
2012
2
Idiopathic juxtafoveal retinal telangiectasis and retinal macroaneurysm treated with indocyanine green dye-enhanced photocoagulation. (23241941)
2012
3
MRI findings in giant pontine capillary telangiectasis associated with a developmental venous anomaly. (22191296)
2011
4
Novel mutation in PANK2 associated with retinal telangiectasis. (20974629)
2011
5
Integrated clinical evaluation of Type 2A idiopathic juxtafoveolar retinal telangiectasis. (19881399)
2010
6
Pulmonary arteriovenous fistula in hereditary hemorrhagic telangiectasis. (19763660)
2009
7
Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. (18703550)
2008
8
Juxtafoveolar telangiectasis associated with CREST syndrome. (18716957)
2008
9
Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. (17120013)
2007
10
Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study. (17619895)
2007
11
Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. (17396701)
2007
12
Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. (17030708)
2006
13
Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis. (16462869)
2006
14
Optical coherence tomography in group 2A idiopathic juxtafoveolar telangiectasis. (16355952)
2005
15
Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. (12652245)
2003
16
Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis. (12875464)
2003
17
Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. (11755857)
2002
18
Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation. (11782226)
2001
19
Bilateral idiopathic retinal telangiectasis, progressive neuroradiological abnormalities and ectodermal dysplasia. (11040916)
2000
20
Retinal telangiectasis and angioid streaks. (11203177)
2000
21
Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. (10484772)
1999
22
Bilateral subretinal neovascular membrane in idiopathic juxtafoveolar telangiectasis. (8865399)
1996
23
Fibrovascular tissue in bilateral juxtafoveal telangiectasis. (8790094)
1996
24
Severe visual loss associated with retinal telangiectasis and facioscapulohumeral muscular dystrophy. (1505769)
1992
25
Superficial retinal refractile deposits in juxtafoveal telangiectasis. (2333929)
1990
26
Paramacular telangiectasis. (3477896)
1986
27
Cavernous hemangioma of the retina and retinal telangiectasis. Distinct or related vascular malformations? (3835616)
1985
28
Peripheral retinal telangiectasis in adults simulating a vascular tumor or melanoma. (6664667)
1983
29
Pulmonary arteriovenous fistula with hereditary hemorrhagic telangiectasis. (7169478)
1982
30
In vitro X-ray sensitivity in ataxia telangiectasis homozygote and heterozygote skin fibroblasts under oxic and hypoxic conditions. (7104995)
1982
31
Idiopathic juxtafoveolar retinal telangiectasis. (7082207)
1982
32
Giant cerebral capillary telangiectasis in an infant. (7094672)
1982
33
Ischemia: a cause of hepatic telangiectasis in cattle. (7103227)
1982
34
DNA-repair synthesis in ataxia telangiectasis lymphoblastoid cells. (6278301)
1981
35
Hereditary hemorrhagic telangiectasis (Rendu-Osler-Weber disease). (7325202)
1981
36
Retinal telangiectasis: delayed response to photocoagulation. (1111411)
1975
37
Clinicopathologic conference. Multiple telangiectasis. (4675175)
1972
38
Neurological manifestations of hereditary haemorrhagic telangiectasis. (5470119)
1970
39
NEUROLOGICAL IMPLICATIONS OF HEREDITARY HEMORRHAGIC TELANGIECTASIS. (14243196)
1964
40
Management of epistaxis in familial haemorrhagic telangiectasis. (13952978)
1963
41
Treatment of thrombosis occurring in individuals with hereditary hemorrhagic telangiectasis; report of three cases including two members of one family. (13292786)
1956
42
Telangiectasis of the retina and Coats' disease. (13339898)
1956
43
Hereditary hemorrhagic telangiectasis with involvement of bone. (13238665)
1955
44
Hemorrhagic telangiectasis: case report. (13053631)
1953
45
Hereditary hemorrhagic telangiectasis treated with rutin. (18098632)
1948
46
Experimentally developed telangiectasis and sawdust liver lesions in rats. (18863408)
1948
47
A case of hereditary haemorrhagic telangiectasis. (20248242)
1947
48
Congenital telangiectasis. (21006330)
1945
49
Case of Large Lymphangioma or Telangiectasis occupying the Lower Half of Left Abdomen and Left Leg. (19984860)
1926
50
Telangiectasis with Epistaxis. (19973609)
1909

Variations for Telangiectasis

About this section

Expression for genes affiliated with Telangiectasis

About this section
Search GEO for disease gene expression data for Telangiectasis.

Pathways for genes affiliated with Telangiectasis

About this section

Pathways related to Telangiectasis according to GeneCards Suite gene sharing:

(show all 41)
idSuper pathwaysScoreTop Affiliating Genes
19.8BMPR2, SMAD4
29.8BMPR2, SMAD4
39.8SMAD4, TGFBR1
49.6TGFB1, TGFBR1
59.3ENG, SMAD4, VEGFA
6
Show member pathways
9.3ENG, TGFB1, TGFBR1
79.3BMPR2, SMAD4, VEGFA
8
Show member pathways
9.2SMAD4, TGFB1, TGFBR1
9
Show member pathways
9.2SMAD4, TGFB1, TGFBR1
109.2SMAD4, TGFB1, TGFBR1
11
Show member pathways
9.2SMAD4, TGFB1, TGFBR1
129.2SMAD4, TGFB1, TGFBR1
13
Show member pathways
9.2BMP6, BMPR2, SMAD4
149.1BMP6, ENG, TGFB1
159.1TGFB1, TGFBR1, VEGFA
169.1TGFB1, TGFBR1, VEGFA
179.0ENG, SMAD4, TGFB1, TGFBR1
18
Show member pathways
9.0ATM, SMAD4, TGFB1, TGFBR1
199.0ATM, SMAD4, TGFB1, TGFBR1
20
Show member pathways
8.9BMPR2, SMAD4, TGFB1, TGFBR1
218.8BMP6, TGFB1, VEGFA
228.7ACVRL1, ENG, SMAD4, TGFB1, TGFBR1
238.7ACVRL1, ENG, SMAD4, TGFB1, TGFBR1
248.7SMAD4, TGFB1, TGFBR1, VEGFA
25
Show member pathways
8.7SMAD4, TGFB1, TGFBR1, VEGFA
268.7SMAD4, TGFB1, TGFBR1, VEGFA
278.7SMAD4, TGFB1, TGFBR1, VEGFA
288.7ATM, BMPR2, SMAD4, TGFBR1, VEGFA
298.6AFP, TGFB1, VEGFA
308.4ACVRL1, BMP6, BMPR2, SMAD4, VEGFA
318.4ATM, SMAD4, TGFB1, TGFBR1, VEGFA
32
Show member pathways
8.3ACVRL1, BMPR2, GDF2, SMAD4, TGFB1, TGFBR1
33
Show member pathways
8.2BMP6, GDF2, SMAD4, TGFB1, TGFBR1
34
Show member pathways
8.0ACVRL1, BMP6, BMPR2, GDF2, TGFB1, TGFBR1
357.8ATM, BMP6, SMAD4, TGFB1, TGFBR1, VEGFA
36
Show member pathways
7.7BMP6, GDF2, SMAD4, TGFB1, TGFBR1, VEGFA
37
Show member pathways
7.6ACVRL1, BMP6, BMPR2, GDF2, SMAD4, TGFB1
38
Show member pathways
7.5ACVRL1, BMP6, BMPR2, SMAD4, TGFB1, TGFBR1
397.5AFP, BMP6, BMPR2, SMAD4, TGFB1, TGFBR1
407.2AFP, BMP6, BMPR2, ENG, SMAD4, TGFB1
41
Show member pathways
6.4ACVRL1, ATM, BMP6, BMPR2, GDF2, SMAD4

GO Terms for genes affiliated with Telangiectasis

About this section

Cellular components related to Telangiectasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1transforming growth factor beta receptor homodimeric complexGO:007002210.3ENG, TGFBR1
2cell surfaceGO:00099867.6ACVRL1, BMPR2, ENG, NDP, TGFB1, TGFBR1
3extracellular spaceGO:00056156.7AFP, BMP6, BMPR2, ENG, GDF2, NDP

Biological processes related to Telangiectasis according to GeneCards Suite gene sharing:

(show all 49)
idNameGO IDScoreTop Affiliating Genes
1endocardial cushion to mesenchymal transitionGO:009050010.7ACVRL1, ENG
2venous blood vessel developmentGO:006084110.6ACVRL1, BMPR2
3positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formationGO:190500710.5ENG, TGFBR1
4response to transforming growth factor betaGO:007155910.5ENG, SMAD4
5endocardial cell differentiationGO:006095610.4SMAD4, SOX18
6regulation of bindingGO:005109810.3SMAD4, TGFB1
7retina vasculature development in camera-type eyeGO:006129810.3ACVRL1, BMPR2
8SMAD protein complex assemblyGO:000718310.3SMAD4, TGFB1
9coronary artery morphogenesisGO:006098210.3TGFBR1, VEGFA
10signal transduction by protein phosphorylationGO:002301410.2ACVRL1, BMPR2, TGFBR1
11dorsal aorta morphogenesisGO:003591210.2ACVRL1, ENG
12positive regulation of axon extension involved in axon guidanceGO:004884210.2BMPR2, VEGFA
13lymphatic endothelial cell differentiationGO:006083610.1ACVRL1, BMPR2, SOX18
14lymphangiogenesisGO:000194610.1ACVRL1, BMPR2, SOX18
15negative regulation of endothelial cell proliferationGO:000193710.1ACVRL1, GDF2, TGFBR1
16artery morphogenesisGO:00488449.9ENG, TGFBR1, VEGFA
17cellular response to transforming growth factor beta stimulusGO:00715609.9ACVRL1, TGFB1, TGFBR1
18negative regulation of DNA biosynthetic processGO:20002799.8ACVRL1, BMPR2, GDF2
19pathway-restricted SMAD protein phosphorylationGO:00603899.8GDF2, TGFB1, TGFBR1
20activin receptor signaling pathwayGO:00329249.8ACVRL1, BMPR2, GDF2, TGFBR1
21regulation of transforming growth factor beta receptor signaling pathwayGO:00170159.7ENG, SMAD4, TGFB1
22positive regulation of epithelial to mesenchymal transitionGO:00107189.7SMAD4, TGFB1, TGFBR1
23positive regulation of bone mineralizationGO:00305019.7BMP6, BMPR2, TGFB1
24positive regulation of endothelial cell differentiationGO:00456039.7ACVRL1, BMP6, GDF2
25cellular iron ion homeostasisGO:00068799.6BMP6, GDF2, SMAD4
26positive regulation of osteoblast differentiationGO:00456699.6BMP6, BMPR2, GDF2
27transforming growth factor beta receptor signaling pathwayGO:00071799.5ACVRL1, SMAD4, TGFB1, TGFBR1
28negative regulation of blood vessel endothelial cell migrationGO:00435379.5ACVRL1, GDF2, TGFB1
29growthGO:00400079.5BMP6, GDF2, VEGFA
30positive regulation of angiogenesisGO:00457669.4ACVRL1, ENG, GDF2, VEGFA
31positive regulation of BMP signaling pathwayGO:00305139.4ACVRL1, BMPR2, ENG, GDF2, SMAD4
32vasculogenesisGO:00015709.3ENG, GDF2, SOX18, VEGFA
33heart developmentGO:00075079.2ATM, ENG, SOX18, TGFBR1
34positive regulation of epithelial cell proliferationGO:00506799.2BMP6, TGFB1, VEGFA
35positive regulation of SMAD protein import into nucleusGO:00603919.1BMP6, SMAD4, TGFB1, TGFBR1
36kidney developmentGO:00018229.1BMP6, SMAD4, TGFBR1, VEGFA
37protein phosphorylationGO:00064689.1ACVRL1, ATM, BMPR2, TGFB1, TGFBR1
38in utero embryonic developmentGO:00017019.0ACVRL1, SMAD4, SOX18, TGFBR1, VEGFA
39cellular response to BMP stimulusGO:00717738.9ACVRL1, BMP6, BMPR2, GDF2, SMAD4
40regulation of apoptotic processGO:00429818.9ATM, BMP6, GDF2, TGFB1
41negative regulation of cell growthGO:00303088.8ACVRL1, BMPR2, GDF2, SMAD4, TGFB1
42BMP signaling pathwayGO:00305098.7ACVRL1, BMP6, BMPR2, ENG, GDF2, SMAD4
43positive regulation of endothelial cell proliferationGO:00019388.5ACVRL1, BMP6, BMPR2, GDF2, TGFBR1, VEGFA
44angiogenesisGO:00015258.5ACVRL1, ENG, GDF2, SOX18, TGFBR1, VEGFA
45SMAD protein signal transductionGO:00603958.4AFP, BMP6, GDF2, SMAD4, TGFB1
46response to hypoxiaGO:00016668.3ACVRL1, ATM, SMAD4, TGFB1, VEGFA
47positive regulation of transcription, DNA-templatedGO:00458938.1ACVRL1, GDF2, NDP, SMAD4, SOX18, TGFB1
48positive regulation of pathway-restricted SMAD protein phosphorylationGO:00108627.9ACVRL1, BMP6, BMPR2, ENG, GDF2, SMAD4
49positive regulation of transcription from RNA polymerase II promoterGO:00459446.8ACVRL1, BMP6, BMPR2, ENG, GDF2, SMAD4

Molecular functions related to Telangiectasis according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1activin bindingGO:004818510.7ACVRL1, ENG
2BMP receptor activityGO:009882110.7ACVRL1, BMPR2
3transmembrane receptor protein serine/threonine kinase activityGO:000467510.7ACVRL1, BMPR2
4transforming growth factor beta-activated receptor activityGO:000502410.6ACVRL1, TGFBR1
5BMP bindingGO:003612210.6BMPR2, ENG
6transforming growth factor beta receptor activity, type IGO:000502510.6ACVRL1, TGFBR1
7type I transforming growth factor beta receptor bindingGO:003471310.5ENG, TGFB1
8growth factor bindingGO:001983810.4BMPR2, TGFBR1
9I-SMAD bindingGO:007041110.4SMAD4, TGFBR1
10transforming growth factor beta bindingGO:005043110.3ACVRL1, ENG, TGFBR1
11type II transforming growth factor beta receptor bindingGO:000511410.0ENG, TGFB1, TGFBR1
12transforming growth factor beta receptor bindingGO:00051609.6BMP6, GDF2, TGFB1
13cytokine activityGO:00051258.7BMP6, GDF2, NDP, TGFB1, VEGFA
14growth factor activityGO:00080838.7BMP6, GDF2, NDP, TGFB1, VEGFA
15protein homodimerization activityGO:00428038.4ENG, NDP, SMAD4, TGFB1, VEGFA
16protein heterodimerization activityGO:00469828.0BMP6, SMAD4, SOX18, TGFB1, VEGFA
17protein bindingGO:00055155.0ACVRL1, AFP, ATM, BMP6, BMPR2, ENG

Sources for Telangiectasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet